PURPOSE of THE NNAST

About us

What is NNAST ?

The fight against antimicrobial resistance (AMR) is a critical battle for Nigeria’s public health.  The unchecked rise of drug-resistant infections threatens to undermine our progress in healthcare, jeopardizing the treatment of common infections and significantly impacting mortality rates.  To effectively combat this threat, a collaborative and coordinated national effort is paramount.

This Taskforce marks a significant step towards achieving this crucial goal and signifies a  renewed commitment  by Nigerian Government to implementing the Nigerian Action Plan on Antimicrobial Resistance 2.0 (NAP 2.0), launched in October 2024 by the NCDC and  Honourable  coordinating Minister of Health and social welfare  Dr. Muhammed Pate.

The launch of NAP 2.0 was necessitated by the alarming escalation of AMR across the country, highlighting the urgent need for a comprehensive and strengthened national strategy.  The previous action plan NAP 1.0 launched in 2017  had made important strides, but the evolving nature of AMR necessitated an updated, robust, and more targeted approach.

NAP 2.0 builds upon the foundations laid by its predecessor, incorporating lessons learned and adapting to the latest scientific evidence and global best practices.  Key features of NAP 2.0 include: strengthened surveillance and detection systems, improved infection prevention and control measures, enhanced stewardship programs in healthcare settings, public awareness campaigns, improved access to diagnostics, improved capacity building, promoting research and development and strengthening healthcare systems

The role of NNAST is pivotal in realizing the ambitions of NAP 2.0 and NCDC  under the One Health plan  and aims to achieve it by;

  1. Supporting the Nigeria Centre for Disease Control (NCDC)

Providing critical support to the NCDC, the lead agency in the fight against AMR, to help achieve the targets outlined in NAP 2.0.  This includes  identifying gaps in funding, collating   information on amr in Nigeria,  providing  advice and technical assistance with setting up National Antimicrobial Stewardship standards,  integrating infectious disease  into educational systems among others.

      2. Facilitating collaborative efforts: Bridging the gap between various government agencies, healthcare providers, research institutions, civil society organizations, educational institutions and international partners to ensure a unified and effective response.

 3. Strengthening communication:  Improving information sharing and coordination among stakeholders, enhancing public awareness about AMR, and promoting evidence-based best practices.

NNAST  represents a collective commitment to a healthier Nigeria. By working together, we can effectively combat AMR and safeguard the future of healthcare for all Nigerians.  We are confident that through collaboration, dedication, and strategic action, we can make significant strides toward achieving the goals outlined in NAP 2.0.  We look forward to a productive partnership in this critical endeavor

NNAST is closely affiliated with the Nigerian Center for Disease Control and Prevention (NCDC)

One of NNAST’s missions is to support NCDC in the battle against antimicrobial resistance by increasing the use of antimicrobial stewardship.

Nigeria’s National Action Plan NAP 2.0 is based on the World Health Organization’s (WHO) recommendations to use  national core elements as indicators of the country’s capacity to implement national programs on Antimicrobial Stewardship (AMS). These core elements are:
1. Establishing a National Plan and Strategies
2. Establishing National regulations and guidelines for awareness
3. Establishing Training and education programs
4. Supporting technologies and data development

Antimicrobial Stewardship is prioritized in the NAP 2.0 governance manual, and a  Technical Working Group (TWG) has been formed to guide its actualization. Collaboration with external groups, government, and non-governmental agencies as well as educational and research groups is encouraged to maximize the efforts to combat AMR.

Nigerian Center for Disease Control and Prevention (NCDC) has established a relationship with the Nigerian National Antimicrobial Stewardship Taskforce (NNAST) that was launched by the Federal Ministry of Health and Social Welfare to implement some of these strategic interventions through an integrated program approach.

NNAST has an advisory and technical role in antimicrobial stewardship in humans and is affiliated with the AMS Pillar of the National AMR Technical Working Group. NNAST has its secretariat within the NCDC.

Scroll to Top

Dr. Omobosola Akinsete is a dedicated physician and a key member of the Nigerian Antimicrobial Stewardship Taskforce. She has been an internal medicine and adult Infectious Disease physician in the United States of America for 30  years . She graduated from Medical school at the University of Lagos, and has a masters in Public Health from Johns Hopkins school of Public Health. 

She did her Internal Medicine training at a Brown University hospital and her fellowship in Infectious Diseases  at the University of Minnesota where she is an associate professor. She has worked with the National Institutes of Health and Howard University a a coordinator for the Human Genome Project among other projects, she is a frequent public speaker and contributor to different types of media. She loves to advocate for healthcare in minority populations. She  has a lot of experience with  patients and health care providers on antimicrobial stewardship in her institution  HealthPartners in Minnesota U.S.A. Her expertise in the field of Infectious diseases and antimicrobial stewardship and her passion to improve health care in her home country will contribute significantly to the fight against antimicrobial resistance in Nigeria. Dr. Akinsete’s work with the taskforce focuses on leadership of the taskforce as chairperson and national coordinator, working closely with NCDC leadership, the Nigerian Federal Ministry of Health, stakeholders, and funding partners, and helping with capacity building of standardized antimicrobial stewardship and infectious disease educational programs. She will also use her expertise to guide providers and HealthCare institutions  on the ground . Her commitment to improving antimicrobial use and patient safety is invaluable to the nation’s public health efforts.